Author(s): Augert A, MacPherson D
Abstract Share this page
Abstract Small cell lung cancer (SCLC) is a devastating tumor type with great therapeutic need. In this issue of Cancer Cell, Christensen and colleagues identify THZ1, a CDK7 inhibitor, as a potential therapy for SCLC. Using cells and mouse models, the authors show exquisite sensitivity of SCLC to transcriptional inhibition. Copyright © 2014 Elsevier Inc. All rights reserved.
This article was published in Cancer Cell
and referenced in Journal of Cancer Science & Therapy